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Abstract
Background: Movement disorders occur in association with stroke and may have important clinical implications.
Methods: We reviewed the medical literature regarding the clinical phenomenology, prevalence, localization and etiologic implications, and treatments for
movement disorders occurring after stroke in adult patients.
Results: Movement disorders occur uncommonly after stroke and include both hyperkinetic and parkinsonian conditions. They can occur at the time of stroke or
appear as a later manifestation. Stroke lesions are typically due to small vessel cerebrovascular disease in the middle or posterior cerebral artery territory, vessels
supplying the basal ganglia. Hemorrhagic lesions are more likely to induce hyperkinetic movements. Movement disorders in the setting of stroke tend to resolve
spontaneously over time. Medical and surgical therapies are available to treat the movement problems.
Discussion: Movement disorders after stroke can be helpful in localizing lesions after stroke, determining the etiology of stroke, may need to be a target for therapy
and may importantly influence long term outcome.
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Introduction
Movement disorders occur uncommonly in association with stroke
in adults and tend to resolve over time. A study of 2,500 first stroke
patients found that 1% developed an acute or delayed movement
disorder.1 In most cases, the lesions were due to small vessel
cerebrovascular disease in the middle or posterior cerebral artery
territories. This is not surprising since the blood supply to the basal
ganglia, the site of pathology for most movement disorders following
stroke, emanates from branches of these vessels.
Hemorrhagic strokes appear to be more likely to lead to movement
disorders than ischemic ones.2 Ninety percent of the acute-onset
movement disorders resolved within 6 months.1 Despite the low
frequency and tendency to resolve, the recognition of a movement
disorder in the setting of stroke can be important in localizing the
lesions and in suggesting an underlying etiology. They may need to be
a target for therapy, and can importantly contribute to disability and
long-term outcome. This review summarizes current knowledge
regarding movement disorders following stroke.
Ballism/chorea
Hemiballism/hemichorea is the most common movement disorder
reported to occur after stroke, present in 40% of cases in a case
series.1 Hemiballism is characterized by vigorous, irregular, poorly
patterned, high-amplitude movements of the limbs on one side of the
body and is often viewed as a severe type of chorea.3 Chorea consists
of brief, arrhythmic, non-repetitive movements that appear to move
from one muscle to the next and is typically worsened by volitional
movements. After stroke, over time as it improves, ballism often
evolves into the lower amplitude chorea. Besides hemiballism, ballism
can involve one limb (monoballism) or all limbs (biballism or
paraballism). In one study of 25 patients with ballism, 19 had
hemiballism.4 The majority of patients with hemiballism have both
choreic and ballistic movement.5 Other commonly associated
dyskinesias include orobuccal, oromandibular, lingual, and dystonic
movements.4,5 It has been reported that 72% of cases of hemiballism
are caused by stroke, with an average age at onset for stroke-induced
hemiballism of 66 years.4
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Among patients with post-stroke hyperkinetic movement disorders,
one of the most common is the lower amplitude hemichorea, with a
prevalence of more than one in every 200 stroke patients.6 After stroke,
hemichorea correlates with motor weakness and mild sensory
symptoms and is often accompanied by athetosis.6,7 Individuals with
post-stroke chorea tend to be older than those with other post-stroke
movement disorders.7
Although there are few reported cases, the most consistent
neuropathological finding in patients with hemiballism after stroke is
an ischemic lesion in the contralateral subthalamic nucleus (STn)
(Figure 1).4 Lesions are occasionally found outside of the STn,
including the caudate nucleus, putamen, and thalamus.4,8 A
neuroimaging study of 22 cases of ballism found that only 4% had a
lesion restricted to the STn, 59% had no evident STn lesion, and the
remainder had lesions of the STn combined with other basal ganglia
or midbrain structures (23%) or cortical lesions (14%).4 An unusual
phenomenon of ipsilateral hemiballism-hemichorea with contralateral
hemiparesis following a basal ganglia lesion has been described.9
One study showed that patients with post-stroke hemichorea tend to
have magnetic resonance imaging (MRI) hyperintensities in the basal
ganglia, particularly the putamen.10 A clinical-radiological correlation
study showed that STn, caudate, putamen, and cortical lesions
contralateral to the affected side were the sites most commonly
associated with hemichorea,6 a localization that is similar to
hemiballism, which is expected given the close phenomenological
relationship of the two disorders.
About 80% of patients with hemiballism experience immediate
onset after stroke, whereas in the others, it is delayed by days, weeks, or
months with the longest reported delay being 5 months.4 As mentioned
earlier, with time, the ballistic movements become less severe and
resemble chorea.11,12 While early studies described hemiballism as a
grave disorder with inexorable progression to death within weeks,
more recently reported cases show evidence of a more benign course
and spontaneous recovery.4 Dewey et al.5 reported spontaneous
recovery in 24% of cases (n 5 21). Survival rate was reported to be
88% after 3 years, with stroke responsible for most deaths, particularly
for deaths soon after onset of the movement disorder.3
Most patients develop the hemichorea within a few days of stroke.
Although rare, hemichorea has been described as a manifestation of a
transient ischemic attack. When chorea is observed in the setting of
cerebrovascular disease, the clinician should consider the possibility of
underlying vasculitis (e.g., systemic lupus erythematosis) or vasculo-
pathy (e.g., paraproteinemia). Chorea has been described in the setting
of stroke due to circulating antiphospholipid antibodies.13 While the
choreic movement does not differ between patients with lesions in
different regions, prognosis does vary depending on the location of the
lesion. In one study, 85% of patients with cortical lesions and 54% of
those with basal ganglia lesions recovered completely, but none of the
patients with isolated lesions in the STn recovered.6
An important condition to distinguish from stroke-induced chorea is
hyperglycemic chorea, which often presents acutely as hemichorea and
may have basal ganglia hyperintensities on MRI. It occurs in the
setting of non-ketotic hyperglycemia (usually blood glucose greater
than 400 mg %) and has been attributed to hyperosmolarity.14,15 Both
the involuntary movements and MRI changes are reversible with
appropriate treatment of the hyperglycemia. It has been suggested that
individuals of Asian descent are more likely to experience this
condition.
Ballism and chorea typically respond to the same therapies. The
most commonly reported pharmacological treatments have been
dopamine receptor blockers, particularly haloperidol.5,6,16–17 One
study reported that 56% of patients with hemiballism treated with
haloperidol experienced resolution of symptoms in 3–15 days.3 Other
reported treatment options include clonazepam and diazepam,6
topiramate, tetrabenazine,18 valproic acid, and, in severe and
persistent cases, local intramuscular injections of botulinum toxin or
ventrolateral thalamotomy.19,20
In one series of patients with post-stroke chorea, while 56% of the
cases resolved within 40 days, other patients had chorea lasting as long
as 41 months.6 Despite absence of published support, we generally
treat disabling ballism or chorea with the atypical dopamine antagonist
drug risperidone since it tends to have fewer side effects than the
classical neuroleptics like haloperidol.Figure 1. Left subthalamic nucleus stroke caused contralateral hemiballism.
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Dystonia
Dystonia consists of involuntary sustained muscle contractions
causing twisting and repetitive movements or abnormal postures. After
hemiballism-hemichorea, dystonia is the second most common
movement disorder after stroke, representing about 20% of cases,1
and often taking the form of focal or hemidystonia. Stroke is the most
common cause of hemidystonia, accounting for nearly 50% of all
cases.21 Nearly all cases of hemidystonia with onset after the age of 50
are due to stroke.22,23 Post-stroke dystonia has been attributed to
lesions of the putamen (the most common site of isolated lesions
causing dystonia), caudate, pallidum, thalamus, and the midbrain.22–24
It has been suggested that dystonia can be induced by an interruption
of the cortico-striato-pallido-thalamo-cortical loop.25 This disturbance,
proposed to be caused by specific lesions of the sensorimotor part of
the striatiopallidal complex and/or the putamen, is thought to increase
thalamocortical drive, which in turn induces dystonia.25 This
hypothesis is consistent with positron emission tomography (PET)
studies, which have shown increased activity in cortical motor areas in
patients with acquired hemidystonia from striatopallidal lesions.26 In
each case, the affected cortical motor area received input from the
pallidonigral thalamic territory.26
In contrast to hemiballism, which typically begins at the time of
stroke, it has been shown that the time between stroke and onset of
dystonia is delayed by an average of 9.5 months, with a range between
3 months and 3 years.21 Dystonia often follows hemiplegia, appearing
once muscle strength begins to recover. Most patients who have onset
of hemidystonia after stroke are young (below age 25), suggesting
increased susceptibility in the younger brain.21 Once present after
stroke, dystonia stabilizes over time, and rarely resolves completely.21
Dystonia following stroke usually has a poor response to medical
therapy, typically being refractory to oral medications. Anticholinergic
drugs,27 benzodiazepines,21 baclofen, and dopamine depleting/block-
ing agents21 have reported benefits for some patients. Local
intramuscular injections of botulinium toxin can lessen stroke-induced
dystonia28 and is probably the best medical approach, particularly
when dystonia is focal and functionally disabling. In one study, surgical
interventions (thalamotomy, pallidotomy, deep brain stimulation
(DBS)) yielded the best results, showing benefit in 96% of treated
patients (n 5 23); however, 39% had only transient improvement.21
The recent literature suggests that DBS of either the thalamus or the
internal globus pallidus appears to be more successful than lesioning
approaches in producing a longer lasting response since its parameters
can be altered for maximum benefit.21 It is still yet to be determined,
however, which target is more effective.21
Myoclonus and asterixis
Myoclonus involves brief, involuntary twitching of muscles or
muscle groups. The literature includes reported cases of myoclonus
after stroke in numerous brain regions, including the frontoparietal
lobes, basal ganglia, midbrain, pons, and cerebellum.29 Thus, the onset
of myoclonus after stroke is not too helpful in localizing the vascular
lesion. Post-stroke myoclonus can affect the arms, legs, face, or voice;
however, facial myoclonus is infrequent after stroke.29
Asterixis, often referred to as negative myoclonus, is characterized
by arrhythmic interruptions of sustained voluntary muscle contraction
causing brief lapses of posture. Asterixis has also been described in
association with stroke. It has been suggested that asterixis may be due
to dysregulation of tracts from the cerebello-brainstem-thalamo-frontal
lobe system.30 Kim30 reported 30 patients with unilateral stroke who
displayed asterixis. Lesions in the thalamus (n 5 19), frontal lobe
(n 5 6), lenticulocapsular area (n 5 1), midbrain (n 5 2), and
cerebellum (n 5 2) were identified.30 Another study described nine
patients with asterixis, four resulting from anterior cerebral artery
infarction.31
Post-stroke myoclonus often does not require treatment. When it
interferes with functional abilities, like eating or writing, the two most
commonly used treatments include clonazepam and sodium valproate,
both GABAergic drugs.32 Other medications that may suppress
myoclonus are piracetam and levitiracetam.32 In our experience,
clonazepam and levitiracetam, sometimes used in combination, are the
most effective medications for myoclonus. The appropriate treatment
for asterixis remains unknown.
Holmes’ tremor
Holmes’ tremor (also called rubral, midbrain, or cerebellar outflow
tremor) is characterized by a resting tremor of a limb with marked
accentuation on action, intention, and goal-oriented movement. It is
typically irregular, of low frequency (,4.5 Hz) and usually involves the
upper extremities.33 Holmes’ tremor has often been described in
association with stroke. Although the most common lesions are in the
brainstem, lesions of the cerebellum and thalamus have also been
reported.34 These localizations suggest involvement of both the
nigrostriatal and dentato-rubro-thalamic pathways,35 and this conclu-
sion has been supported by MRI.36 In this study, all three patients with
Holmes’ tremor following brainstem stroke showed hypertrophy of the
inferior olivary nucleus, suggesting that disruption of the denato-
rubral-olivary circuitry may play a key role.36
The onset of Holmes’ tremor after stroke is typically delayed by
weeks to months.36 Drugs that have reported benefit include
propranolol, clonazepam, levodopa, other dopaminergic agents,
valproate, and levetiracetam.37 We consider levodopa as first line.
However, response to drugs is usually poor in these patients37 and
because of the poor response to medications, many patients with
Holmes’ tremor require surgical intervention,38 such as ventrointer-
medius thalamotomy38 and thalamic DBS.39,40
Palatal tremor
Palatal tremor consists of brief, rhythmic involuntary movements of
the soft palate.41 The condition was previously described as palatal
myoclonus, but was renamed since the rhythmic nature makes it more
accurately classified as a tremor. Stroke is one of the most common
causes of symptomatic palatal tremor (SPT).41 SPT patients have other
signs of cerebellar dysfunction, abnormalities on motor learning tasks
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and brainstem reflex testing, and the palatal tremor persists and varies
in rate during sleep.41 Imaging studies show lesions in the triangle of
Guillain–Mollaret (red nucleus, inferior olive, dentate nucleus) and an
enlarged inferior olivary nucleus.41 The triangle of Guillain–Mollaret
functions as a feedback loop between the brainstem and cerebellar
nuclei that controls spinal cord motor activity.
Despite the suggestion of a hypertrophied inferior olivary nucleus
(Figure 2) as the cause of SPT,41 autopsy studies have shown that
hypertrophic olivary degeneration (HOD) does not correlate with the
presence or absence of SPT.42 Imaging studies have shown that
pontine tegmental, cerebellar, and dentate nuclear lesions all cause
HOD.43 The dentate nucleus is involved in control of volitional
movement, suggesting that HOD is a sign of the lesion in the triangle
of Guillain–Mollaret that causes the SPT, rather than the direct cause
of the palatal tremor. The onset of SPT has been suggested to depend
on hyperactivity of olivary neurons, while its persistence is due to a
disturbance of natural rhythmicity in the circuitry because of a loss of
feedback.42
One study showed a 2- to 49-month delay in onset of palatal tremor
after acute stroke. When stroke related, SPT tends not to resolve
spontaneously, particularly when associated with other cerebellar
dysfunction.41 SPT generally manifests itself to the patient with an
audible clicking sound. This may be tolerable and not require specific
treatment. When intolerable or functionally impairing, however, the
most commonly reported and our preferred treatment for SPT has
been local intramuscular botulinum toxin injections.44
Tics
Tics consist of involuntary twitches (motor tics) or sounds (phonic
tics). There are a few case reports of tics developing after stroke
localized to the basal ganglia45–47 and one case following hemorrhage
of a left frontal arteriovenous malformation.48 If disabling, tics can be
treated with alpha-receptor agonists (clonidine, guanfacine) or
dopamine receptor antagonists such as risperidone or fluphenazine.
Vascular parkinsonism
Stroke in critical locations, such as the midbrain and basal ganglia,
can cause the acute onset of parkinsonism. It is also now appreciated
that patients with chronic small vessel cerebrovascular disease can
develop a progressive condition characterized by features resembling
Parkinson’s disease (PD). Termed ‘‘vascular parkinsonism’’, this
condition is now considered a distinct, although heterogeneous,
clinical entity.49,50 Vascular parkinsonism is clinically manifested
primarily by bilateral, symmetric bradykinesia and rigidity (idiopathic
PD typically begins on one side and tends to be asymmetric), usually in
the presence of a gait disorder. Presentation can be as ‘‘lower half
parkinsonism’’, in which there is rigidity and bradykinesia of the legs
with sparing of the upper extremities, often accompanied by start
hesitation (gait ignition failure) and gait freezing.51 Resting tremor may
be present in vascular parkinsonism, but it is usually mild. Levodopa
and other dopaminergic drugs may improve vascular parkinsonism,52
but the effects are usually modest and short-lived. On brain
neuropathologic examination, patients with vascular parkinsonism
Figure 2. Bilateral inferior olivary hypertrophy (post mortem).
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show evidence of widespread, mostly subcortical small vessel
cerebrovascular disease and they do not have the characteristic
Lewy body (synucleinopathic) pathology of PD. Two forms of
leukoencephalopathy, Binswanger’s disease53 and CADASIL (cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy),54 and Moyamoya disease55 can present with
vascular parkinsonism.
It can be difficult to clinically differentiate vascular parkinsonism
and PD. Studies attempting to accurately classify cases rely either on
clinically accepted criteria or autopsy findings. It has been shown that
misdiagnosis of vascular parkinsonism as PD is common with rates of
misdiagnosis of 15–30%.56,57 One reason for diagnostic confusion may
be that studies of vascular parkinsonism have not carefully distin-
guished between true signs of parkinsonism (resting tremor, lead pipe
rigidity, bradykinesia, parkinsonian gait) that reflect nigrostriatal
dysfunction from the pseudoparkinsonian signs (action tremor or
myoclonus, paratonic rigidity, apraxic slowness, apraxic gait) that
reflect multifocal or diffuse hemispheric dysfunction that would be
expected in patients with cerebrovascular disease.58
Conclusions
Movement disorders occur uncommonly in association with stroke
and tend to resolve over time. Nevertheless, their recognition in the
setting of stroke can be important in localizing the lesions and in
suggesting an underlying etiology. Most strokes associated with
movement disorders involve small vessel branches of the middle or
posterior cerebral arteries since these supply the basal ganglia, the
usual site of pathology. The movement disorders can appear acutely at
the time of the stroke or they can have a delayed onset. The most
commonly observed disorders are hemiballism-hemichorea and
dystonia, but other hyperkinetic and hypokinetic disorders can occur
as well. The movement disorders may need to be a target for therapy
since they can contribute to disability. A variety of medications,
botulinum toxin injections, and stereotactic neurosurgical procedures
are available to treat these conditions. The features of movement
disorders after strokes are summarized in Table 1.
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